Abstract
Herein, a selected set of chiral N1-(4-oxochromen-7-yl)-4,5-dihydro-1,2,4-triazin-6(1H)-ones (7a-k / 8a-k) were prepared via direct interaction of L-α-amino esters with N1-(4-oxochromen-7-yl) nitrile imines (generated in situ from their hydrazonoyl chloride precursors 5a,b by the action of triethylamine). These novel dihydrotriazinone-flavone hybrid compounds (7), their 2- methylchromenone analogs (8) and the L-proline homologs (9,10) were characterized by microanalytical and spectral (HRMS and NMR) data. Compounds 7a and 7i displayed good activity against (MCF-7) breast cancer.
Keywords: 7-Aminoflavone, 7-amino-2-methylchromen-4-one, 4-oxo-N-(chromen-7-yl)hydrazonoyl chlorides, antitumor activity L-α-amino esters, nitrileimine, substituted dihydro-1, 2, 4-triazin-6-ones, bactericidal, inhibitory, fungicidal, antiviral
Letters in Organic Chemistry
Title:Synthesis of Some 1-(Flavon-7-yl)-4,5-dihydro-1,2,4-triazin-6(1H)-ones and Related Congeners
Volume: 9 Issue: 7
Author(s): Marwa N. Abu-Aisheh, Mohammad S. Mustafa, Mohammad S. Mubarak, Mustafa M. El-Abadelah and Wolfgang Voelter
Affiliation:
Keywords: 7-Aminoflavone, 7-amino-2-methylchromen-4-one, 4-oxo-N-(chromen-7-yl)hydrazonoyl chlorides, antitumor activity L-α-amino esters, nitrileimine, substituted dihydro-1, 2, 4-triazin-6-ones, bactericidal, inhibitory, fungicidal, antiviral
Abstract: Herein, a selected set of chiral N1-(4-oxochromen-7-yl)-4,5-dihydro-1,2,4-triazin-6(1H)-ones (7a-k / 8a-k) were prepared via direct interaction of L-α-amino esters with N1-(4-oxochromen-7-yl) nitrile imines (generated in situ from their hydrazonoyl chloride precursors 5a,b by the action of triethylamine). These novel dihydrotriazinone-flavone hybrid compounds (7), their 2- methylchromenone analogs (8) and the L-proline homologs (9,10) were characterized by microanalytical and spectral (HRMS and NMR) data. Compounds 7a and 7i displayed good activity against (MCF-7) breast cancer.
Export Options
About this article
Cite this article as:
N. Abu-Aisheh Marwa, S. Mustafa Mohammad, S. Mubarak Mohammad, M. El-Abadelah Mustafa and Voelter Wolfgang, Synthesis of Some 1-(Flavon-7-yl)-4,5-dihydro-1,2,4-triazin-6(1H)-ones and Related Congeners, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139573
DOI https://dx.doi.org/10.2174/157017812802139573 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Review
Combinatorial Chemistry & High Throughput Screening Induction of Apoptosis by Pierisin-6 in HPV Positive HeLa and HepG2 Cancer Cells is Mediated by the Caspase-3 Dependent Mitochondrial Pathway
Anti-Cancer Agents in Medicinal Chemistry Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Plant Mediated Silver Nanoparticles and Mode of Action in Cancer Therapy: A Review
Anti-Cancer Agents in Medicinal Chemistry Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?
Current Drug Targets Synthesis, In Vitro Activities of (2-Cyclopropoxyphenyl)piperidine Derivatives for α1a and α1d Adrenergic Receptor Inhibitors
Medicinal Chemistry Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Current Medicinal Chemistry Monoclonal Antibodies: A Review
Current Clinical Pharmacology A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization
Current Cancer Drug Targets The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Current Cancer Drug Targets Editorial (Thematic Issue: Endocrine Related Cancer: From Stem Cells to New Drug Targets)
Current Medicinal Chemistry Isoflavones, their Glycosides and Glycoconjugates. Synthesis and Biological Activity
Current Organic Chemistry Production and Application of Copper Radiopharmaceuticals
Current Radiopharmaceuticals Exploring and Exploiting Biologically Relevant Chemical Space
Current Drug Targets Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
Current Pharmaceutical Design Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies
Current Cancer Therapy Reviews May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing Trials
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
Current Medicinal Chemistry The Role of the Anti-Amyloidogenic Secretase ADAM10 in Shedding the APP-like Proteins
Current Alzheimer Research